Skip to main content
. 2021 Jul 29;12:673103. doi: 10.3389/fphar.2021.673103

FIGURE 7.

FIGURE 7

Analysis of ROS generation using DC-FDA staining on CaSki cells treated with PEITC for 24 h and the images were captured by fluorescence microscopy. (A) PEITC treatment resulted in significant production of ROS in cervical cancer cells. (B) Percent cell viability of PEITC treated (20, 25 and 30 μM) CaSki cells was assessed in the presence of ROS inhibitor, NAC, by MTT assay. The data represents mean ±SD of three independent experiments. *p value < 0.05 compared with the untreated control was considered statistically significant.